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A 32-year-old Hispanic man presented with a long-term
history of weight loss and progressive dermatosis and a 2-month
history of occasional postprandial emesis after solid bolus
intake. He referred to having had unprotected sex with multiple
male partners and denied any other medical background or
sexually transmitted disease. On physical examination, dissemi-
nated violaceous skin lesions were observed in patches (FigureFigure 1. Extensive Kaposi’s sarcoma in an HIV-infected man. (A) Multiple violaceous 
erythematous nodules in gastric body and fundus; (D) positive HHV-8 immunohistoch
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1A), as well as plaques and a right-ankle exophytic tumor
(Figure 1B).
During general workup, a fourth-generation HIV ELISA test was
positive. His baseline HIV-1 RNA load was 760 000 copies/ml and
CD4+ T-cell count was 93 cells/mm3. A thoraco-abdominal and
limb computed tomography (CT) scan revealed para-aortic
lymphadenopathy and discarded lung and bone involvement.
Biopsy of the ankle tumor was performed, showing positive
immunohistochemical analysis results for human herpesvirus 8dorsolumbar skin lesions; (B) right-ankle tumor and KS plaques; (C) gastroscopy:
emistry of gastric nodule biopsy.
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Gastroscopy revealed multiple erythematous nodules in the gastric
body and fundus (Figure 1C), with histological analysis positive for
HHV-8 (Figure 1D).
KS is considered an AIDS-defining illness, therefore highly
active antiretroviral therapy (HAART) was started as soon as
possible in the hospital. This was well tolerated. Eventually, the
patient was discharged after counseling, specific instructions, and
scheduled systemic chemotherapy. Unfortunately, the patient was
lost to follow-up. This is an example of a patient with advanced
manifestations of AIDS in an environment of wide socio-economic
and cultural limitations.
KS is in the spectrum of angioproliferative malignancies. It is
mainly caused by HHV-8 and is known as the most common
malignancy in HIV/AIDS patients (Curtiss et al., 2016; Hoffmann
et al., 2017). In 2010, the most common cancers among HIV-
infected people in the USA were non-Hodgkin lymphoma
(incidence 21%) and KS (incidence 12%). In Sub-Saharan Africa,
KS and cervical cancer are the most common cancers in this
population (Shiels and Engels, 2017).
The burden of KS has declined during the HAART era, although
mainly in developed countries. However, low-income countries
(including Mexico) have also experienced a reduction in the
incidence through improvements in local programs and interna-
tional assistance (Shiels and Engels, 2017; Rezende et al., 2015). The
range of clinical manifestations is broad, from localized skin
lesions to extensive involvement of the internal organs. Gastric KS
is the most frequent extracutaneous site, and concomitant skin
lesions can be found in 80% of patients with gastric involvement
(Rezende et al., 2015).
An HIV RNA viral load >100 000 copies/ml and CD4+ T-cell
count <200 cells/mm3 are well known risk factors for KS (Rezende
et al., 2015; Goncalves et al., 2017). The differential diagnosis in this
case scenario should include consideration of hemangioma,
bacillary angiomatosis, mycobacterial infections, leiomyosarcoma,
angiosarcoma, and other high-grade vascular tumors. Histopatho-
logical analysis is the mainstay of workup to confirm the diagnosis
(Hoffmann et al., 2017).
The cornerstone of treatment for AIDS-associated KS involves
the initiation of HAART. This results in an increase in CD4+ T-cell
count, which can suppress the HHV-8 virus. Visceral involvement
is related to an unfavorable prognosis, despite the combination of
systemic chemotherapy and HAART (Hoffmann et al., 2017;
Goncalves et al., 2017).Funding: No specific grant from any funding agency in the
public, commercial, or not-for-profit sectors was received for this
article.
Ethical approval: Not required.
Conflict of interest: No competing interest declared.
References
Curtiss P, Strazzulla LC, Friedman-Kien AE. An update on Kaposi’s sarcoma:
epidemiology, pathogenesis and treatment. Dermatol Ther (Heidelb) 2016;6
(4):465–70.
Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R. Kaposi sarcoma herpesvirus-
associated cancers and related diseases. Curr Opin HIV AIDS 2017;12:47–56.
Hoffmann C, Sabranski M, Esser S. HIV-associated Kaposi’s sarcoma. Oncol Res Treat
2017;40:94–8.
Rezende RE, Kahwage RL, da Costa TV, Machado AA, Brunaldi MO, Kemp R, et al.
Upper gastrointestinal Kaposi’s sarcoma in HIV-infected patients: ten years of
endoscopy observation at a single Brazilian center. Int J Infect Dis 2015;39:110–
5.
Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr
Opin HIV AIDS 2017;12(1):6–11.
Isaí Medina-Piñóna
Martín Wah-Suárezb
Luis Arturo Acosta-Calderónc
Javier Ramos-Jiméneza,*
aInfectious Diseases Service, Hospital Universitario “Dr. José E.
González” and Medical School, Universidad Autónoma de Nuevo León,
Monterrey, Mexico
bInternal Medicine Department, Hospital Universitario “Dr. José E.
González” and Medical School, Universidad Autónoma de Nuevo León,
Monterrey, Mexico
cAnatomical Pathology and Cytopathology Department, Hospital
Universitario “Dr. José E. González” and Medical School, Universidad
Autónoma de Nuevo León, Monterrey, Mexico
* Corresponding author at: Infectious Diseases Service, Hospital
Universitario “Dr. José E. González”, Universidad Autónoma de
Nuevo León, Madero y Gonzalitos S/N, Monterrey, NL 64460,
Mexico.
E-mail address: javier.ramosj@uanl.mx (J. Ramos-Jiménez).
Corresponding Editor: Eskild Petersen, Aarhus, Denmark
Received 6 November 2017
Received in revised form 6 December 2017
Accepted 9 December 2017
